Author

L. Pongor

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Assay:DNA methylation· 3 Organism:human· 3 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:clustering· 1

Frequent Co-Authors

A. Thomas· 2 shared A. Bekesi· 1 shared A. Grinshpun· 1 shared A. Hubert· 1 shared A. Luna· 1 shared A. Poti· 1 shared A. Rajan· 1 shared A. Salah· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Thomas

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Subtyping of Small Cell Lung Cancer using plasma cell-free nucleosomes

G. Fialkoff, N. Takahashi, I. Sharkia, J. Gutin, N. Hermoni, R. Kumar, L. Pongor, S. Nichols, L. Sciuto, C. Graham, P. Desai, M. Nirula, P. Suresh, M. Abel, R. Elmeskini, , A. Thomas

This study uses cfChIP-seq on plasma samples to subtype SCLC based on epigenetic states, linking plasma nucleosome data to tumor transcriptomes and developing a classifier for lineage-defining transcription factors.

bioRxiv · Jun 24, 2022 · PreprintCancer Biology

SCLC_CellMiner: Integrated Genomics and Therapeutics Predictors of Small Cell Lung Cancer Cell Lines based on their genomic signatures

C. Tlemsani, L. Pongor, L. Girard, N. Roper, F. Elloumi, S. Varma, A. Luna, V. N. Rajapakse, R. Sebastian, K. W. Kohn, J. Krushkal, M. Aladjem, B. Teicher, P. S. Meltzer, W. C. Reinhold, , Y. Pommier

SCLC_CellMiner provides an integrated resource of 118 SCLC cell lines with omics data and drug sensitivity, identifying molecular subtypes and therapeutic targets.

bioRxiv · Mar 9, 2020 · PreprintCancer Biology

Genome-wide alterations of uracil distribution patterns in human DNA upon chemotherapeutic treatments

H. L. Palinkas, A. Bekesi, G. Rona, L. Pongor, G. Tihanyi, E. Holub, A. Poti, C. Gemma, S. Ali, M. J. Morten, E. Rothenberg, M. Pagano, D. Szuts, B. Gyorffy, B. G. Vertessy

The paper investigates genome-wide uracil distribution changes in human cells after chemotherapy, finding drug-induced shifts toward active genomic regions.

bioRxiv · Mar 4, 2020Biochemistry